UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 62

Sortiert nach

Neoadjuvant endocrine therapy in locally advanced estrogen or progesterone receptor-positive breast cancer: determining the optimal endocrine agent and treatment duration in postmenopausal women—a literature review and proposed guidelines

Breast cancer research : BCR, 2020-07, Vol.22 (1), p.1-13, Article 77

2020

Volltextzugriff (PDF)

Human anogenital monocyte-derived dendritic cells and langerin+cDC2 are major HIV target cells

Nature communications, 2021-04, Vol.12 (1), p.2147-2147, Article 2147

2021

Volltextzugriff (PDF)

Non-overlapping progesterone receptor cistromes contribute to cell-specific transcriptional outcomes

PloS one, 2012-04, Vol.7 (4), p.e35859-e35859

2012

Volltextzugriff (PDF)

Emerging functional roles of nuclear receptors in breast cancer

Journal of molecular endocrinology, 2017-04, Vol.58 (3), p.R169-R190

2017

Volltextzugriff (PDF)

Minireview: Progesterone Regulation of Proliferation in the Normal Human Breast and in Breast Cancer: A Tale of Two Scenarios?

Molecular endocrinology (Baltimore, Md.), 2015-09, Vol.29 (9), p.1230-1242

2015

Volltextzugriff (PDF)

Identification of HIV transmitting CD11c + human epidermal dendritic cells

Nature communications, 2019-06, Vol.10 (1), p.2759-15, Article 2759

2019

Volltextzugriff (PDF)

Innovative thiosemicarbazones that induce multi-modal mechanisms to down-regulate estrogen-, progesterone-, androgen- and prolactin-receptors in breast cancer

Pharmacological research, 2023-07, Vol.193, p.106806-106806, Article 106806

2023

Volltextzugriff (PDF)

Novel RU486 (mifepristone) analogues with increased activity against Venezuelan Equine Encephalitis Virus but reduced progesterone receptor antagonistic activity

Scientific reports, 2019-02, Vol.9 (1), p.2634, Article 2634

2019

Volltextzugriff (PDF)

Impact of the EndoPredict genomic assay on treatment decisions for oestrogen receptor-positive early breast cancer patients: benefits of physician selective testing

Breast cancer research and treatment, 2022-02, Vol.191 (3), p.501-511

2022

Volltextzugriff (PDF)

Distinct nuclear receptor expression in stroma adjacent to breast tumors

Breast cancer research and treatment, 2013-11, Vol.142 (1), p.211-223

2013

Volltextzugriff (PDF)

A tumour suppressive relationship between mineralocorticoid and retinoic acid receptors activates a transcriptional program consistent with a reverse Warburg effect in breast cancer

Breast cancer research : BCR, 2020-11, Vol.22 (1), p.122-16, Article 122

2020

Volltextzugriff (PDF)

Progesterone receptor A predominance is a discriminator of benefit from endocrine therapy in the ATAC trial

Breast cancer research and treatment, 2015-06, Vol.151 (2), p.309-318

2015

Volltextzugriff (PDF)

Estrogen and progesterone signalling in the normal breast and its implications for cancer development

Molecular and cellular endocrinology, 2018-05, Vol.466, p.2-14

2018

Volltextzugriff (PDF)

The multifaceted role of the mineralocorticoid receptor in cancers

The Journal of steroid biochemistry and molecular biology, 2024-09, Vol.242, p.106541, Article 106541

2024

Volltextzugriff (PDF)

Profiling differential microRNA expression between in situ, infiltrative and lympho-vascular space invasive breast cancer: a pilot study

Clinical & experimental metastasis, 2018-02, Vol.35 (1-2), p.3-13

2018

Volltextzugriff (PDF)

Binding sites analyser (BiSA): software for genomic binding sites archiving and overlap analysis

PloS one, 2014-02, Vol.9 (2), p.e87301-e87301

2014

Volltextzugriff (PDF)

Ductal Carcinoma in Situ: Molecular Changes Accompanying Disease Progression

Journal of mammary gland biology and neoplasia, 2022-03, Vol.27 (1), p.101-131

2022

Volltextzugriff (PDF)

Preview: MCE special issue on molecular mechanisms of action in progesterone signalling

Molecular and cellular endocrinology, 2012-06, Vol.357 (1-2), p.1-3

2012

Volltextzugriff (PDF)

Acquired convergence of hormone signaling in breast cancer: ER and PR transition from functionally distinct in normal breast to predictors of metastatic disease

Oncotarget, 2014-09, Vol.5 (18), p.8651-8664

2014

Volltextzugriff (PDF)

Changed lineage composition is an early event in breast carcinogenesis

Histology and histopathology, 2013-09, Vol.28 (9), p.1197

2013

Volltextzugriff (PDF)

Bioinformatic analysis of cis-regulatory interactions between progesterone and estrogen receptors in breast cancer

PeerJ (San Francisco, CA), 2014-11, Vol.2, p.e654-e654

2014

Volltextzugriff (PDF)

Artificial intelligence‐based digital scores of stromal tumour‐infiltrating lymphocytes and tumour‐associated stroma predict disease‐specific survival in triple‐negative breast cancer

The Journal of pathology, 2023-05, Vol.260 (1), p.32-42

2023

Volltextzugriff (PDF)

Breast cancer prognosis predicted by nuclear receptor-coregulator networks

Molecular oncology, 2014-07, Vol.8 (5), p.998-1013

2014

Volltextzugriff (PDF)

GCUNC-45 Is a Novel Regulator for the Progesterone Receptor/hsp90 Chaperoning Pathway

Molecular and Cellular Biology, 2006-03, Vol.26 (5), p.1722-1730

2006

Volltextzugriff (PDF)

Focal Subnuclear Distribution of Progesterone Receptor Is Ligand Dependent and Associated with Transcriptional Activity

Molecular endocrinology (Baltimore, Md.), 2007-01, Vol.21 (1), p.14-29

2007

Volltextzugriff (PDF)

1 – 25 von 62

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(60)
Mit Volltextzugriff
(61)

Publikationsform

Artikel
(61)
Tagungsberichte
(1)

Sprache

Erscheinungsjahr

n.n

Thema

Science & Technology
(54)
Humans
(48)
Life Sciences & Biomedicine
(46)
Female
(37)
Breast Cancer
(24)
Breast Neoplasms - Genetics
(20)
Oncology
(18)
Endocrinology & Metabolism
(16)
Receptors, Progesterone - Metabolism
(16)
Breast Neoplasms - Metabolism
(15)
Breast Neoplasms - Pathology
(15)
Animals
(12)
Receptors, Progesterone - Genetics
(12)
Prognosis
(11)
Biological And Medical Sciences
(10)
Gene Expression Regulation, Neoplastic
(10)
Gene Expression
(9)
Tumors
(9)
Biochemistry & Molecular Biology
(8)
Cancer
(8)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Neoadjuvant endocrine therapy in locally advanced estrogen or progesterone receptor-positive breast cancer: determining the optimal endocrine agent and treatment duration in postmenopausal women—a literature review and proposed guidelines

Human anogenital monocyte-derived dendritic cells and langerin+cDC2 are major HIV target cells

Non-overlapping progesterone receptor cistromes contribute to cell-specific transcriptional outcomes

Emerging functional roles of nuclear receptors in breast cancer

Minireview: Progesterone Regulation of Proliferation in the Normal Human Breast and in Breast Cancer: A Tale of Two Scenarios?

Identification of HIV transmitting CD11c + human epidermal dendritic cells

Innovative thiosemicarbazones that induce multi-modal mechanisms to down-regulate estrogen-, progesterone-, androgen- and prolactin-receptors in breast cancer

Novel RU486 (mifepristone) analogues with increased activity against Venezuelan Equine Encephalitis Virus but reduced progesterone receptor antagonistic activity

Impact of the EndoPredict genomic assay on treatment decisions for oestrogen receptor-positive early breast cancer patients: benefits of physician selective testing

Distinct nuclear receptor expression in stroma adjacent to breast tumors

A tumour suppressive relationship between mineralocorticoid and retinoic acid receptors activates a transcriptional program consistent with a reverse Warburg effect in breast cancer

Progesterone receptor A predominance is a discriminator of benefit from endocrine therapy in the ATAC trial

Estrogen and progesterone signalling in the normal breast and its implications for cancer development

The multifaceted role of the mineralocorticoid receptor in cancers

Profiling differential microRNA expression between in situ, infiltrative and lympho-vascular space invasive breast cancer: a pilot study

Binding sites analyser (BiSA): software for genomic binding sites archiving and overlap analysis

Ductal Carcinoma in Situ: Molecular Changes Accompanying Disease Progression

Preview: MCE special issue on molecular mechanisms of action in progesterone signalling

Acquired convergence of hormone signaling in breast cancer: ER and PR transition from functionally distinct in normal breast to predictors of metastatic disease

Changed lineage composition is an early event in breast carcinogenesis

Bioinformatic analysis of cis-regulatory interactions between progesterone and estrogen receptors in breast cancer

Artificial intelligence‐based digital scores of stromal tumour‐infiltrating lymphocytes and tumour‐associated stroma predict disease‐specific survival in triple‐negative breast cancer

Breast cancer prognosis predicted by nuclear receptor-coregulator networks

GCUNC-45 Is a Novel Regulator for the Progesterone Receptor/hsp90 Chaperoning Pathway

Focal Subnuclear Distribution of Progesterone Receptor Is Ligand Dependent and Associated with Transcriptional Activity

Suchergebnisse filtern